What are the treatment options for locally advanced Prostate Cancer

Prostate CancerMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Treatment Options for Locally Advanced Prostate Cancer

Locally advanced prostate cancer means the cancer has grown beyond the prostate itself but hasn't spread to distant sites like bones or organs. According to the NCCN Guidelines for Patients: Advanced-Stage Prostate Cancer, here are your main treatment approaches:

Primary Treatment Options

1. Radiation Therapy (External Beam Radiation)

This is a standard approach where focused radiation beams target the prostate and surrounding tissue. Radiation can be delivered in different ways:

  • Standard external beam radiation therapy (EBRT)
  • Stereotactic body radiation therapy (SBRT) - delivers higher doses in fewer treatments
  • Proton therapy - an alternative form of radiation

2. Surgery (Radical Prostatectomy)

Surgical removal of the prostate gland, often combined with removal of nearby lymph nodes (pelvic lymph node dissection). This is a definitive local treatment option.

3. Combination Approaches (Most Common)

According to the NCCN Guidelines, locally advanced prostate cancer is typically treated with combination therapy rather than single treatments alone:

Radiation + Hormone Therapy (ADT)

  • Androgen deprivation therapy (ADT) - drugs that lower testosterone - is often added to radiation
  • This combination improves outcomes compared to radiation alone
  • ADT may be given for a defined period (typically 2-3 years)

Surgery + Hormone Therapy

  • Radical prostatectomy combined with ADT
  • Pelvic lymph node dissection is often performed to assess lymph node involvement

Important Diagnostic Considerations

Before treatment planning, your care team will typically perform:

  • PSMA PET scans - specialized imaging that helps identify if cancer has spread to lymph nodes or distant sites
  • Genetic/genomic testing - to identify specific mutations that might guide treatment selection
  • MRI imaging - to assess local extent of disease

Key Treatment Decision Factors

Your oncologist will consider:

  • Gleason score (how aggressive the cancer appears)
  • PSA level (prostate-specific antigen - a tumor marker)
  • Extent of local spread (how far beyond the prostate)
  • Lymph node involvement
  • Your age and overall health
  • Your preferences regarding surgery vs. radiation

Questions to Ask Your Healthcare Team

  1. Based on my specific staging and risk factors, do you recommend surgery, radiation, or a combination approach?

  2. If you're recommending hormone therapy (ADT), how long would I take it, and what are the side effects I should expect?

  3. What imaging studies (PSMA PET, MRI) do you recommend to fully stage my cancer before treatment?

  4. Should I have genetic testing of my tumor to look for specific mutations that might guide treatment?

  5. What are the long-term side effects of the treatment you're recommending, and how will we monitor for them?

  6. Are there clinical trials available for my stage of disease?


Important Context from Expert Sources

According to expert guidance from the CancerPatientLab webinars on prostate cancer treatment, the standard approach to locally advanced disease has evolved significantly. Treatment intensification is now standard of care - meaning doctors typically combine approaches rather than using single treatments alone. The combination of local therapy (surgery or radiation) with systemic hormone therapy has been shown to improve survival outcomes.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: